Pfizer

News

Pfizer/Lilly non-opioid pain drug hits mark in phase 3 trial

After years of delays Pfizer and Eli Lilly’s tanezumab non-opioid pain drug is edging closer to approval, after it met targets in an osteoarthritis trial.

R&D

Pfizer moves haemophilia gene therapy into phase 3

US pharma giant Pfizer and partner Spark Therapeutics has begun a phase 3 trial of a gene therapy for patients with haemophilia B, which could see an end to patients needing constant inject

M&A

Pfizer splits into three after failing to sell consumer unit

Pfizer has decided to split into three after it failed to sell its consumer healthcare business a few months ago.

News

Pfizer defers drug price hike after Trump phone call

Pfizer has decided to defer the recent drug price increase after a long discussion with president Trump and HHS secretary.

News

Trump strikes Pfizer over price increases

The US president took his frustration to twitter criticising Pfizer and “others” for the recent price increase and “taking advantage of Americans”, but there is really not much he can do to

News

Pharma takes leading role in NHS 70th anniversary celebratio...

The pharmaceutical industry celebrated the 70th anniversary of the NHS by recognising the myriad contributions that the sector has made to the lives of many people.

Pfizer/Lilly non-opioid pain drug hits mark in phase 3 trial

Pfizer moves haemophilia gene therapy into phase 3

Pfizer splits into three after failing to sell consumer unit

Pfizer defers drug price hike after Trump phone call

Trump strikes Pfizer over price increases

Pharma takes leading role in NHS 70th anniversary celebratio...

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

Pfizer

Editor's Picks